Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Exercise of Options and Total Voting Rights

27th Feb 2026 12:11

RNS Number : 7565U
Aminex PLC
27 February 2026
 

27 February 2026

 

Aminex plc

 ("Aminex" or "the Company")

 

Exercise of Options and Total Voting Rights

 

Aminex announces that it has issued a total of 1,500,000 ordinary shares of €0.001 each following the exercise of options by a former employee under the Aminex PLC Share Option Scheme (the "Option Shares"). The exercise will provide £21,000 of additional funding to the Company, which will be used for general working capital purposes.

 

Applications will be made to the Financial Conduct Authority ("FCA") and the London Stock Exchange for the Option Shares to be admitted to the FCA's Official List (Equity Shares (transition)) and to trading on the main market of the London Stock Exchange ("Admission"). It is expected that Admission will become effective and that dealings will commence in the Option Shares at 8.00 a.m. (London time) on 6 March 2026. Following Admission, the enlarged share capital and the total voting rights of the Company will be 4,470,001,044. The Company does not hold any shares in treasury.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

For further information:

 

Aminex PLC

+44 203 355 9909

Charles Santos, Executive Chairman

Knights Media & Public Relations

+44 203 653 0200

Jason Knights, Anthea Pitt

Davy

+353 1 679 6363

Brian Garrahy

 

Shard Capital

+44 20 7186 9952

Damon Heath

Axis Capital Markets

+44 203 026 0320

Richard Hutchison

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESEUFEWEMSESE

Related Shares:

Aminex
FTSE 100 Latest
Value10,910.55
Change63.85